U.S. Pharmacist Weekly News Update
September 4, 2019

Psychiatric Drugs Aren’t
Barriers to Success in
Weight-Loss Program

Patients taking psychiatric drugs might be concerned that it will affect their weight loss, but that doesn’t appear to be the case with weight-management programs. Find out how the medications affected how many pounds were dropped in those taking psychiatric drugs versus those who were not.


New Drugs Underused for Resistant Infection Despite Pharmacists’ Push
A survey of hospital pharmacists showed that they were strong proponents of using powerful new drugs to combat carbapenem-resistant Enterobacteriaceae. So why are the antibiotics underprescribed for the dangerous condition? Here is what researchers posited.

AHA Issues New Scientific Advisory on Prescription
Omega-3 Fatty-Acid Benefits

Prescription omega-3 fatty acid medications effectively reduce extremely high triglyceride levels for most patients who require treatment, according to a new American Heart Association scientific statement. The authors advise against OTC products, however. Here is more information.

Oral Steroid Type Doesn’t Appear to Matter in Childhood Croup
Winter is coming and so is croup. Usually, Infants and toddlers who have laryngotracheobronchitis are prescribed either prednisolone or low-dose dexamethasone. Responding to concerns that an evidence base for treatment was lacking, a new study has determined that the type of oral steroid doesn’t seem to make a difference. Find out more.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App
https://ad.doubleclick.net/ddm/clk/435751642;238386182;n https://ad.doubleclick.net/ddm/clk/435751375;238462309;m